Skip to main content

Suliman Shehnaaz

In the past year, 4 open-market sale filings worth $936.1K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$936.1K
4 filings
Net
−$936.1K
Bought minus sold
Companies
2
With open-market trades

Trades

Every Form 4 that lists Suliman Shehnaaz as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

TXG 10x Genomics, Inc.

Director3 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 24, 2026 (view filing)4:30 PM ETSep 222 daysSuliman ShehnaazDirectorSSaleClass A Common Stock−5.72K$81.19−$464.7K−19.4%23.8K after5 lots10b5-1
Aug 26, 2026 (view filing)4:42 PM ETAug 242 daysSuliman ShehnaazDirectorSSaleClass A Common Stock−2.21K$63.65−$140.5K−7.0%29.5K after2 lots10b5-1
Jun 18, 2026 (view filing)Jun 162 daysSuliman ShehnaazDirectorSSaleClass A Common Stock−5.72K$32.63−$186.8K−15.3%31.7K after2 lots10b5-1

RARE Ultragenyx Pharmaceutical Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 18, 2026 (view filing)May 18Same daySuliman ShehnaazDirectorSSale−5.74K$25.12−$144.2K−17.0%28.0K after10b5-1

ALEC Alector, Inc.

President and COO2 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 14, 2021 (view filing)Dec 10-134 daysSuliman ShehnaazPresident and COOSSale−150.0K$21.50−$3.23M−59.4%102.6K after4 lots
Dec 10, 2021 (view filing)Dec 8-92 daysSuliman ShehnaazPresident and COOSSale−150.0K$22.81−$3.42M−59.4%102.6K after4 lots